Overview over the individual characteristics, treatment data and complications in patients with venous thromboembolic events (VTEs)
| Case | Age, sex | History of VTE | DC | Location of VTE | Anticoagulation | Target aPTT (in seconds) | Complications |
| 1 | 40–49, f | PE | Yes | DVT, PE | UFH | 50–60 | – |
| 2 | 70–79, m | – | Yes | DVT, PE | UFH | 50–60 | Splenic haemorrhage and rupture after initial splenic infarction |
| 3 | 50–59, m | – | Yes | DVT | UFH | 60–80 | – |
| 4 | 40–49, m | DVT | Yes | PE | LMWH | – | – |
| 5 | 40–49, m | – | Yes | Central venous catheter (femoral vein) | UFH | 50 | – |
| 6 | 60–69, f | – | Yes | Central venous catheter (femoral vein) | UFH | 50 | – |
| 7 | 60–69, f | – | Yes | Central venous catheter (femoral vein) | UFH | 40–50 | – |
| 8 | 60–69, m | – | Yes | DVT | UFH | 50–60 | Asymptomatic intracranial bleeding into the infarcted tissue |
| 9 | 50–59, m | – | Yes | PE | UFH | 50–60 | – |
| 10 | 50–59, m | – | Yes | DVT | UFH | 50–60 | – |
| 11 | 60–69, m | – | Yes | PE | UFH | 50–60 | – |
| 12 | 60–69, m | – | No | Central venous catheter (internal jugular vein) | UFH | 50–60 | – |
| 13 | 60–69, f | DVT | No | PE | Fondaparinux | – | – |
| 14 | 70–79, m | – | No | Central venous catheter (internal jugular vein) | UFH | 50–60 | – |
| 15 | 50–59, m | – | No | PE | UFH | 50–60 | Bleeding from a duodenal ulcer |
aPTT, activated partial thromboplastin time; DC, decompressive craniectomy; DVT, deep vein thrombosis; f, female; LMWH, low-molecular-weight heparin; m, male; PE, pulmonary embolism; UFH, unfractionated heparin.